A newly published study by authors from Singapore focused on the ability of the SEP protocol – short-term low-dose enoxaparin administration based on body weight – to maintain the patency of an arteriovenous (A-V) shunt after recurrent thrombosis.
Don‘t have an account? Create new account
Authors: Prof. MUDr. Jan Kvasnička, DrSc.
Enter the email address that you registered with. We will send you instructions on how to set a new password.
